News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Artisan Pharma, Inc.'s Lead Product, ART-123, Approved in Japan


2/22/2008 8:32:25 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Artisan Pharma, Inc. today announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan’s lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation (“DIC”) in Japan.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES